Scientific article

Diabète et stéatose hépatique non alcoolique

Published inRevue médicale suisse, vol. 8, no. 344, p. 1211-1214
Publication date2012

NAFLD (non-alcoholic fatty liver disease) is the most frequent chronic liver disease and is frequently associated with diabetes. Its pathogenesis is complex and consists in hepatocyte fat accumulation, inflammation and mitochondrial dysfunction. Its diagnosis is based on imaging and blood tests to exclude other causes of liver disease. Liver biopsy remains the gold-standard in case of doubt. Medications have relatively little efficacy and the main measures to treat NAFLD are weight loss and exercise. Although controversies exist, NALFD is now considered as a cardiovascular risk factor in diabetes and it is therefore important to treat all cardiovascular risk factors.

  • Diabetes Complications
  • Fatty Liver/diagnosis/etiology/therapy
  • Humans
  • Risk Factors
Citation (ISO format)
GARIANI, Karim, PHILIPPE, Jacques, JORNAYVAZ, François. Diabète et stéatose hépatique non alcoolique. In: Revue médicale suisse, 2012, vol. 8, n° 344, p. 1211–1214.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation12/05/2013 11:17:00 AM
First validation12/05/2013 11:17:00 AM
Update time03/14/2023 8:42:21 PM
Status update03/14/2023 8:42:21 PM
Last indexation08/29/2023 8:14:12 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack